Developer docs
API playgroundTry for free, no card

Search company profiles

Lirio

Full company profile

uuid0000ekg

Namestring
Lirio
Legal namestring
Lirio, Inc.
Websiteurl
lirio.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Lirio is a Knoxville, Tennessee-based behavioral science and AI company that delivers personalized patient and member engagement solutions to healthcare organizations. The company's core product, Precision Nudging, combines proprietary behavioral science methodology with a Large Behavior Model (LBM) — a reinforcement-learning-based AI — to identify psychological, emotional, and contextual barriers preventing health actions and to deliver timely, tailored messages that drive individual behavior change. The platform processes 400M+ nudges per year and supports n-of-1 personalization across the patient journey. Lirio sells primarily through enterprise contracts to four healthcare verticals: health systems, payers, life sciences, and retail pharmacy, with named customers including Covenant Health, Cone Health, Rochester Regional Health, Kroger, Truth Initiative, and Ayin Health Solutions. Distribution is a hybrid of direct enterprise field sales and, since October 2025, the Microsoft Marketplace with Azure and Dynamics 365 integrations; the company is also a member of the AWS Health Equity Initiative.

Lirio's commercial model is a quote-based enterprise SaaS subscription, with pricing not publicly disclosed. The company holds HITRUST CSF, SOC 2 Type II, and NIST certifications, which are prerequisites for selling into large integrated delivery networks, payers, and federal health buyers. The platform integrates with customers' existing CRM, data warehouse, and marketing automation stacks rather than replacing them, positioning Lirio as a behavioral intelligence layer that sits above incumbent healthcare IT infrastructure. The company was founded in 2016-2017, originally operating in financial and energy sectors before pivoting exclusively to healthcare via the launch of Lirio Health in January 2019. Leadership includes CEO Marten den Haring (formerly CPO, prior SVP of Platform at Element AI and CPO at Digital Reasoning), Chief Behavioral Officer Amy Bucher, Ph.D. (formerly VP at One Drop and faculty at Vanderbilt), and Chief AI Scientist Christopher Symons, Ph.D. (formerly at Oak Ridge National Laboratory).

Capital structure: privately held, with approximately $65M raised across nine funding events between 2016 and 2022. Strategic investors have included Bon Secours Mercy Health (two rounds), HDHGV Fund 1, and WR Hambrecht. The company is headquartered in Knoxville with a secondary office in Franklin, Tennessee, and reports a headcount of 51-100 employees. No revenue or ARR has been publicly disclosed, and there have been no disclosed funding rounds since mid-2022, suggesting either capital efficiency or a gap in growth-stage fundraising that would warrant diligence.

Short descriptiontext

Lirio is a Knoxville-based healthcare AI company that uses its proprietary Large Behavior Model and behavioral science methodology (Precision Nudging) to deliver n-of-1 personalized patient engagement to health systems, payers, life sciences firms, and retail pharmacies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersKnoxville, United States
HQ citystring
Knoxville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
behavioral engagement platform, patient engagement software, healthcare AI personalization, precision nudging solutions, behavior change AI
Industry2 codes
PRIMARYHLALAFAF
Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLALAFAK
Behavioral Health-Integrated Chronic Care (SUD comorbidity, collaborative care)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
NAICS code1 code
  • Software Publishers5132
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Healthcare Patient Engagement Software
Social media profiles3 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Software Platform Subscription
TypeSubscription Recurring
Description

Lirio provides its Precision Nudging platform as a software solution to healthcare organizations. The platform is sold as a subscription to health systems, life sciences companies, health plans, and retail pharmacy organizations for patient engagement and behavior change campaigns.

lirio.com
2Securities Offering
TypeLicensing Royalties
Description

SEC Form D filings indicate the company has conducted securities offerings in the United States, including a $27.5 million offering (2022) and a $3 million convertible notes offering (2022).

sec.gov
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Lirio provides a behavioral science and agentic AI platform branded as Precision Nudging that identifies psychological, emotional, and contextual barriers preventing health actions and delivers personalized, n-of-1 outreach messages to patients and members. The platform is sold as a subscription to enterprise healthcare organizations across health systems, payers, life sciences, and retail pharmacy segments, with vertical-specific solution configurations tailored to each segment's engagement challenges.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 4x more effective than standard health messages
+6 more records
Product overview1 text field

Lirio is a behavioral science and agentic AI platform that offers a unified product architecture centered on its Precision Nudging solution. The core platform combines behavioral science with agentic AI to deliver hyper-personalized patient and consumer engagement across healthcare. The product portfolio includes specialized solutions for Health Systems, Life Sciences (including Precision Nudging for Life Sciences), Payers, and Retail Pharmacy, each tailored to address specific engagement challenges including medication adherence, vaccine uptake, care gap closure, and chronic condition management. The platform delivers over 400 million nudges per year, personalizing messages, channels, and timing for each individual.

Product and service1 record
1Precision Nudging
Scale indicator17 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-10-16
Description

Lirio's Precision Nudging solution is now available in Microsoft Marketplace, enabling healthcare organizations worldwide to discover and deploy the solution with seamless integration across Microsoft Azure and Microsoft Dynamics 365.

Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2023-07-06
Description

Partnership to expand Truth Initiative's EX Program tobacco cessation outreach using AI and Precision Nudging to drive greater reach to employees and members.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2023-04-28
Description

Value-based care partnership for population health management services and community-based healthcare delivery solutions.

4Cone Health
Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2023-03-21
Description

Partnership aims to improve the patient experience, close gaps in care, and advance health equity. Co-created patient nudges resulting in clinically meaningful outcomes.

lirio.com
Strategic tierStrategicTypeTechnology or IntegrationAnnounced on2023-02-28
Description

Selected as part of the AWS Health Equity Initiative, a $40 million three-year commitment supporting organizations developing solutions to advance health equity. Lirio receives AWS credits and customized technical expertise.

Strategic tierStrategicTypeImplementation/ SI/ Consulting PartnerAnnounced on2022-03-08
Description

Strategic alliance focused on enabling healthcare providers to deliver more personalized care through Lirio's behavior change AI platform.

Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2019-01-02
Description

Strategic alliance to optimize communication between healthcare organizations and patients they serve. Lirio Health leverages machine learning and AI to help empower people to be full partners in their healthcare.

8Kroger
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Kroger's in-store pharmacies partner with Lirio to offer high-touch, personalized patient engagement experiences through Kroger's retail pharmacy network.

lirio.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

mPulse Mobile delivers mobile-first healthcare engagement and behavior change programs to payers, providers, and pharmacies. It competes most directly with Lirio in personalized outreach for medication adherence, care gap closure, and member activation.

TypeDirect peer
Description

Upfront Healthcare provides a patient activation platform using personalized outreach and microsurveys to drive visit completion and care gap closure, serving many of the same health system customers as Lirio.

TypeDirect peer
Description

Conversa Health offers automated, AI-driven patient conversations for chronic care management, discharge follow-up, and care gap closure — overlapping directly with Lirio's Precision Nudging use cases across health systems.

TypeDirect peer
Description

Welltok's consumer activation platform drives personalized health and wellbeing outreach for payers and providers. It competes with Lirio in member engagement, care gap closure, and behavior change campaigns.

TypeDirect peer
Description

OptimizeRx delivers AI-driven patient and provider engagement at the point of care for life sciences organizations, directly overlapping with Lirio's newly launched Precision Nudging for Life Sciences offering.

TypeDirect peer
Description

Xealth enables clinicians to digitally prescribe content, apps, and services to patients within the EHR workflow. It is a peer in the digital health engagement layer for health systems, though focused more on prescription of programs than behavioral messaging.

TypeBroad incumbent
Description

Salesforce Health Cloud is a major CRM platform used by health systems and payers for patient/member engagement. As a broad incumbent, it competes with Lirio via native personalization and journey orchestration features.

TypeBroad incumbent
Description

Microsoft Cloud for Healthcare bundles patient engagement, care management, and analytics capabilities. Although Lirio is also a Microsoft Marketplace partner, the underlying Microsoft stack represents the most consequential incumbent competitive threat.

TypeEmerging player
Description

Twill (formerly Happify Health) delivers digital therapeutics and care programs for mental health, MS, and psoriasis. It overlaps with Lirio in digital behavior change and condition-specific coaching, though focused more on self-directed programs.

TypeEmerging player
Description

Memora Health uses AI to automate patient follow-up and care navigation across text and chat, competing with Lirio in patient outreach for health systems but with less of a behavioral science foundation.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds9 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Lirio

Healthcare Patient Engagement Softwarelirio.com

Lirio is a Knoxville-based healthcare AI company that uses its proprietary Large Behavior Model and behavioral science methodology (Precision Nudging) to deliver n-of-1 personalized patient engagement to health systems, payers, life sciences firms, and retail pharmacies.

What Lirio does

Lirio is a Knoxville, Tennessee-based behavioral science and AI company that delivers personalized patient and member engagement solutions to healthcare organizations. The company's core product, Precision Nudging, combines proprietary behavioral science methodology with a Large Behavior Model (LBM) — a reinforcement-learning-based AI — to identify psychological, emotional, and contextual barriers preventing health actions and to deliver timely, tailored messages that drive individual behavior change. The platform processes 400M+ nudges per year and supports n-of-1 personalization across the patient journey. Lirio sells primarily through enterprise contracts to four healthcare verticals: health systems, payers, life sciences, and retail pharmacy, with named customers including Covenant Health, Cone Health, Rochester Regional Health, Kroger, Truth Initiative, and Ayin Health Solutions. Distribution is a hybrid of direct enterprise field sales and, since October 2025, the Microsoft Marketplace with Azure and Dynamics 365 integrations; the company is also a member of the AWS Health Equity Initiative.

Lirio's commercial model is a quote-based enterprise SaaS subscription, with pricing not publicly disclosed. The company holds HITRUST CSF, SOC 2 Type II, and NIST certifications, which are prerequisites for selling into large integrated delivery networks, payers, and federal health buyers. The platform integrates with customers' existing CRM, data warehouse, and marketing automation stacks rather than replacing them, positioning Lirio as a behavioral intelligence layer that sits above incumbent healthcare IT infrastructure. The company was founded in 2016-2017, originally operating in financial and energy sectors before pivoting exclusively to healthcare via the launch of Lirio Health in January 2019. Leadership includes CEO Marten den Haring (formerly CPO, prior SVP of Platform at Element AI and CPO at Digital Reasoning), Chief Behavioral Officer Amy Bucher, Ph.D. (formerly VP at One Drop and faculty at Vanderbilt), and Chief AI Scientist Christopher Symons, Ph.D. (formerly at Oak Ridge National Laboratory).

Capital structure: privately held, with approximately $65M raised across nine funding events between 2016 and 2022. Strategic investors have included Bon Secours Mercy Health (two rounds), HDHGV Fund 1, and WR Hambrecht. The company is headquartered in Knoxville with a secondary office in Franklin, Tennessee, and reports a headcount of 51-100 employees. No revenue or ARR has been publicly disclosed, and there have been no disclosed funding rounds since mid-2022, suggesting either capital efficiency or a gap in growth-stage fundraising that would warrant diligence.

Lirio firmographics

Firmographics
Name
Lirio
Legal name
Lirio, Inc.
Website
https://lirio.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
101–250 employees
Short description
Lirio is a Knoxville-based healthcare AI company that uses its proprietary Large Behavior Model and behavioral science methodology (Precision Nudging) to deliver n-of-1 personalized patient engagement to health systems, payers, life sciences firms, and retail pharmacies.
Ownership category
akta.pro rank

Lirio industry classification

Industry
Product category
Healthcare Patient Engagement Software
NAICS
Software Publishers (5132)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLALAFAF
Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLALAFAK
Behavioral Health-Integrated Chronic Care (SUD comorbidity, collaborative care)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms

Keywords

  • Behavioral engagement platform
  • Patient engagement software
  • Healthcare AI personalization
  • Precision nudging solutions
  • Behavior change AI

Where Lirio is headquartered

Location

Headquarters

HQ city
Knoxville
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Lirio business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Software Platform Subscription: Lirio provides its Precision Nudging platform as a software solution to healthcare organizations. The platform is sold as a subscription to health systems, life sciences companies, health plans, and retail pharmacy organizations for patient engagement and behavior change campaigns.
  2. Securities Offering: SEC Form D filings indicate the company has conducted securities offerings in the United States, including a $27.5 million offering (2022) and a $3 million convertible notes offering (2022).

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Lirio product offering

Product offering

Core offering

Lirio provides a behavioral science and agentic AI platform branded as Precision Nudging that identifies psychological, emotional, and contextual barriers preventing health actions and delivers personalized, n-of-1 outreach messages to patients and members. The platform is sold as a subscription to enterprise healthcare organizations across health systems, payers, life sciences, and retail pharmacy segments, with vertical-specific solution configurations tailored to each segment's engagement challenges.

Product overview

Lirio is a behavioral science and agentic AI platform that offers a unified product architecture centered on its Precision Nudging solution. The core platform combines behavioral science with agentic AI to deliver hyper-personalized patient and consumer engagement across healthcare. The product portfolio includes specialized solutions for Health Systems, Life Sciences (including Precision Nudging for Life Sciences), Payers, and Retail Pharmacy, each tailored to address specific engagement challenges including medication adherence, vaccine uptake, care gap closure, and chronic condition management. The platform delivers over 400 million nudges per year, personalizing messages, channels, and timing for each individual.

Differentiator

Problem solved

Functional benefit

Products and services

  • Precision Nudging

Quantifiable outcome

  • 4x more effective than standard health messages
  • +6 more outcomes

Companies that use Lirio

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles4 records

Lirio technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability5 records

Feature5 records

Lirio partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core, strategic and minor.

  • MicrosoftcoreTechnology or Integration · 16 October 2025Lirio's Precision Nudging solution is now available in Microsoft Marketplace, enabling healthcare organizations worldwide to discover and deploy the solution with seamless integration across Microsoft Azure and Microsoft Dynamics 365.
  • Truth InitiativestrategicStrategic or Co-development Partner · 6 July 2023Partnership to expand Truth Initiative's EX Program tobacco cessation outreach using AI and Precision Nudging to drive greater reach to employees and members.
  • Ayin Health SolutionsminorStrategic or Co-development Partner · 28 April 2023Value-based care partnership for population health management services and community-based healthcare delivery solutions.
  • Cone HealthstrategicStrategic or Co-development Partner · 21 March 2023Partnership aims to improve the patient experience, close gaps in care, and advance health equity. Co-created patient nudges resulting in clinically meaningful outcomes.
  • Amazon Web Services (AWS)strategicTechnology or Integration · 28 February 2023Selected as part of the AWS Health Equity Initiative, a $40 million three-year commitment supporting organizations developing solutions to advance health equity. Lirio receives AWS credits and customized technical expertise.
  • NTT DATAstrategicImplementation/ SI/ Consulting Partner · 8 March 2022Strategic alliance focused on enabling healthcare providers to deliver more personalized care through Lirio's behavior change AI platform.
  • Rochester Regional HealthstrategicStrategic or Co-development Partner · 2 January 2019Strategic alliance to optimize communication between healthcare organizations and patients they serve. Lirio Health leverages machine learning and AI to help empower people to be full partners in their healthcare.
  • KrogerminorStrategic or Co-development PartnerKroger's in-store pharmacies partner with Lirio to offer high-touch, personalized patient engagement experiences through Kroger's retail pharmacy network.

Scale indicators17 records

Recent moves7 records

Expansion highlights5 records

Lirio competitors and assessment

Company assessment

Direct peers

  • mPulse Mobile: mPulse Mobile delivers mobile-first healthcare engagement and behavior change programs to payers, providers, and pharmacies. It competes most directly with Lirio in personalized outreach for medication adherence, care gap closure, and member activation.
  • Upfront Healthcare: Upfront Healthcare provides a patient activation platform using personalized outreach and microsurveys to drive visit completion and care gap closure, serving many of the same health system customers as Lirio.
  • Conversa Health: Conversa Health offers automated, AI-driven patient conversations for chronic care management, discharge follow-up, and care gap closure — overlapping directly with Lirio's Precision Nudging use cases across health systems.
  • Welltok: Welltok's consumer activation platform drives personalized health and wellbeing outreach for payers and providers. It competes with Lirio in member engagement, care gap closure, and behavior change campaigns.
  • OptimizeRx: OptimizeRx delivers AI-driven patient and provider engagement at the point of care for life sciences organizations, directly overlapping with Lirio's newly launched Precision Nudging for Life Sciences offering.
  • Xealth: Xealth enables clinicians to digitally prescribe content, apps, and services to patients within the EHR workflow. It is a peer in the digital health engagement layer for health systems, though focused more on prescription of programs than behavioral messaging.

Broad incumbents

  • Salesforce Health Cloud: Salesforce Health Cloud is a major CRM platform used by health systems and payers for patient/member engagement. As a broad incumbent, it competes with Lirio via native personalization and journey orchestration features.
  • Microsoft Cloud for Healthcare: Microsoft Cloud for Healthcare bundles patient engagement, care management, and analytics capabilities. Although Lirio is also a Microsoft Marketplace partner, the underlying Microsoft stack represents the most consequential incumbent competitive threat.

Emerging players

  • Twill: Twill (formerly Happify Health) delivers digital therapeutics and care programs for mental health, MS, and psoriasis. It overlaps with Lirio in digital behavior change and condition-specific coaching, though focused more on self-directed programs.
  • Memora Health: Memora Health uses AI to automate patient follow-up and care navigation across text and chat, competing with Lirio in patient outreach for health systems but with less of a behavioral science foundation.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

Lirio social profiles

Digital presence

Lirio compliance and trust

Trust signal

Compliance3 records

Lirio financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Lirio leadership team

Management profile

Number of profiles

Profiles5 records

Lirio funding detail

Funding detail

Funding overview

Funding rounds9 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Lirio M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lirio

What does Lirio do?

Lirio provides a behavioral science and agentic AI platform branded as Precision Nudging that identifies psychological, emotional, and contextual barriers preventing health actions and delivers personalized, n-of-1 outreach messages to patients and members. The platform is sold as a subscription to enterprise healthcare organizations across health systems, payers, life sciences, and retail pharmacy segments, with vertical-specific solution configurations tailored to each segment's engagement challenges.

Is Lirio a public or private company?

Lirio is a private company. It is classified as venture growth investor backed and is currently operating.

When was Lirio founded?

Lirio was founded in 2017. It employs 101 to 250 people.

Where is Lirio based?

Lirio is headquartered in Knoxville, United States, in the North America region.

How does Lirio make money?

Two revenue lines are on record. Software Platform Subscription is the primary driver. The others are securities Offering.

Who are Lirio's main competitors?

Direct peers on record are mPulse Mobile, Upfront Healthcare, Conversa Health, Welltok, OptimizeRx and Xealth. Broad incumbents are Salesforce Health Cloud and Microsoft Cloud for Healthcare. Emerging players are Twill and Memora Health.

Does Lirio have an API?

No public API is recorded for Lirio.

What industry is Lirio in?

Lirio's product category is Healthcare Patient Engagement Software. Its primary akta.pro industry code is HLALAFAF, Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs), with a secondary code of HLALAFAK, Behavioral Health-Integrated Chronic Care (SUD comorbidity, collaborative care). Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FiercePharmaQuality over quantity: Healthcare messages not tuned into patient needs, survey findsA survey of 1,500 U.S. adults found 58% said healthcare communications don't consistently feel relevant to their needs. Nearly one in four cited irrelevant or generic content as a top reason for ignoring messages. Lirio's CEO said organizations that treat relevance as a performance metric will create lasting patient relationships.MobiHealthNewsQ&A: Lirio uses messaging approach around vaccinationsLirio's research found personalized text messages boosted vaccine rates by 20% versus standard pharmacy messaging. The company uses autonomy-support language, which works equally well for pro- and anti-vaccine individuals. Lirio is also exploring infant vaccines, including measles, though no messaging has been deployed yet.YahooHLTH Europe 2026: enriching the patient journey with health technologiesAt the HLTH Europe 2026 conference in Amsterdam from June 15-18, healthcare, pharma, and health technology leaders discussed innovations to improve patient adherence, a long-standing challenge in treatment outcomes. Key solutions presented included AI-powered personalized patient outreach systems (Lirio), gamified rehabilitation devices (Ai2Ai's PALL0), FDA-cleared smart sharps bins with medication reminders (HealthBeacon), and connected medication dispensing machines (PicoCare). Panelists emphasized that pharma must shift toward patient-centered partnerships with payers, healthcare systems, and advocacy groups to navigate the regulatory landscape and effectively address adherence barriers.Medical Device NetworkHLTH Europe 2026: enriching the patient journey with health technologiesHLTH Europe 2026 took place in Amsterdam from June 15–18, bringing together healthcare, pharma, and health technology experts to discuss patient adherence technologies and how the pharma sector can better engage patients throughout their treatment journey. Several health technology companies showcased or discussed innovations aimed at improving long-term adherence, including Lirio's AI-powered personalized outreach platform, Ai2Ai's gamified adherence device PALL0, and HealthBeacon's FDA-cleared smart sharps bin for medication monitoring. Panelists emphasized the need for flexible, affordable, and engaging adherence tools, noting that healthcare systems must now implement available solutions to reduce burden on overstretched services.PharmiWeb.comNew Life Sciences Survey Reveals Traditional Personalization Models Fail to Build Trust and Motivate PatientsLirio released a report based on surveys with 75 executives from life sciences companies, conducted by Sage Growth Partners, revealing that traditional in-house personalization solutions fail to deliver improved patient engagement. The survey found that nearly 50 percent of patients do not take medications as prescribed, resulting in $100 billion annually in preventable healthcare costs and 125,000 avoidable deaths, with over 70 percent of executives identifying clinical trial patient engagement and medication adherence as their most persistent challenges. Lirio also announced its Precision Nudging for Life Sciences solution following its signing of the CMS Health Technology Ecosystem Pledge.Pulse 2.0Lirio: Interview With Chief Behavioral Officer Amy Bucher, PhD About The Personalized Engagement PlatformLirio's Chief Behavioral Officer Amy Bucher described the company's AI-driven Precision Nudging platform, which uses behavioral science and reinforcement learning to personalize patient engagement. The platform has achieved results such as 60% of unengaged patients completing a primary care visit and 52% of diabetics improving HbA1c within six months. Lirio plans to expand globally in 2025.FierceHealthcareHealth system execs bullish on automation for patient outreach but back-office AI often prioritizedA survey by Lirio and Sage Growth Partners found that 60% of U.S. health system executives cite automating patient outreach as their top priority, yet 83% have invested AI in back-office operational efficiency while only 35% have invested in AI for patient engagement. The survey of 150 executives reveals a disconnect between stated priorities and actual AI investment strategies, with experts noting that operational AI tools demonstrate faster, clearer ROI than patient engagement technologies that require behavioral changes over time. Covenant Health, a Tennessee-based health system, is highlighted as an early adopter working with Lirio since 2023 to use AI-based patient outreach for preventative health screenings.MedCity NewsWhy AI Is Falling Short on Patient Engagement at HospitalsA study commissioned by patient engagement startup Lirio and conducted by Sage Growth Partners reveals that only 5% of U.S. health system executives are satisfied with current AI tools for patient engagement. The research highlights a gap between booming investments in clinical AI and the lagging effectiveness of AI in addressing challenges like medication adherence and missed appointments. Industry experts argue that shifting to an 'N-of-1 personalization' model using agentic AI is necessary to effectively scale tailored patient outreach.TechTargetHealth execs say AI boosts patient outreach, but investment lagsA survey of 79 healthcare executives conducted by Sage Growth Partners and commissioned by Lirio found that while 96% of respondents believe AI could reduce administrative burden in patient outreach, only about a third have invested in AI-powered patient outreach tools. The survey revealed a significant investment mismatch, with 83% having invested in AI for automated documentation—more than double those who invested in patient outreach. The researchers suggested this represents a missed opportunity for healthcare organizations, particularly given that over half of leaders reported struggling with some aspect of patient communication.Business Wire BlogLirio Debuts Behavioral-Science Backed Patient Engagement Solution for Life Sciences OrganizationsLirio announced the launch of Precision Nudging®, a behavioral science and agentic AI platform designed to help pharmaceutical and biotechnology companies improve patient engagement and medication adherence. The solution utilizes personalized messaging to address behavioral barriers, aiming to enhance treatment initiation, persistence, and overall patient outcomes across the care journey.